Skip to main content
Top
Published in: Rheumatology International 9/2021

01-09-2021 | Knee Osteoarthritis | Art in RMD

Diet in osteoarthritis

Author: Ilke Coskun Benlidayi

Published in: Rheumatology International | Issue 9/2021

Login to get access

Excerpt

Diet plays an important role in the course of osteoarthritis. Obesity due to the imbalance between physical exercise and caloric intake impairs body biomechanics and also influences disease progression by increasing load on weight-bearing joints, knees in particular. The altered load distribution deteriorates cartilage homeostasis, leading to joint degeneration. Currently, inflammation is also considered in the context of both osteoarthritis and obesity. Particularly, abnormal biomechanics and overproduction of inflammatory markers, leptin and other adipokines (cytokines secreted by adipose tissue), intensify inflammatory activity in osteoarthritis.
Metadata
Title
Diet in osteoarthritis
Author
Ilke Coskun Benlidayi
Publication date
01-09-2021
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 9/2021
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04379-5

Other articles of this Issue 9/2021

Rheumatology International 9/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.